NCT00377273View on ClinicalTrials.gov

An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratoses

PHASE4CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

November 30, 2003

Study Completion Date

October 31, 2005

Conditions
Actinic Keratoses
Interventions
DRUG

fluorouracil cream 0.5%

Trial Locations (1)

08807

Sanofi-Aventis, Bridgewater

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00377273 - An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratoses | Biotech Hunter | Biotech Hunter